To report three cases of bullous pemphigoid in patients treated with vildagliptin. Case 1: An
86‐year‐old woman presented with bullous pemphigoid after 1 month of treatment with …

High-dose baclofen, ie, 300 mg/d or more, has recently emerged as a strategy for treating
alcohol dependence. The impact that the co-exposure of large amounts of alcohol and …

Background The gamma-aminobutyric acid type B receptor agonist baclofen is approved for
spasticity and is used off-label for diverse types of addictive disorders, notably alcohol …

Background and Objective The concern surrounding the association between Guillain–Barré
syndrome (GBS) and vaccination has increased with the widespread use of COVID-19 …

Objectives. The aim of this research was to describe the cases of TNF-α antagonist-related
alopecia reported in the French Pharmacovigilance Database (FPVD) and to investigate the …

BackgroundTo assess the efficacy and safety of topiramate in treating binge eating disorder
(BED), using a systematic review and meta-analysis of the available randomized clinical …

Objective To report the prospective follow-up of pregnancies exposed to misoprostol during
the first trimester and analyse the teratogenic risk depending on the indication for use. Study …

Introduction Gabapentinoids are ligands of the α2-δ subunit of voltage-gated calcium channels
(Cav) that have been associated with a risk of peripheral edema and acute heart failure …

Oseltamivir is a neuraminidase inhibitor approved for the prevention and treatment of influenza.
Few haematological side effects have been reported with oseltamivir. We report herein …

In France, the off-label use of high-dose baclofen (HDB) for alcohol dependence is spreading.
HDB induces frequent neuropsychiatric adverse events (AEs). Borderline personality …